Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions

RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration

(2015) Carol D. Hamilton et al.   CLINICAL INFECTIOUS DISEASES

WHO's new End TB Strategy

(2015) Mukund Uplekar et al.   LANCET

Tuberculosis diagnostics: which target product profiles should be prioritised?

(2014) S. V. Kik et al.   EUROPEAN RESPIRATORY JOURNAL

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

(2014) Alimuddin I Zumla et al.   LANCET INFECTIOUS DISEASES

Fundamental research is the key to eliminating TB

(2014) Christian Lienhardt   NATURE

A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis

(2014) Corinne S. Merle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

(2014) Stephen H. Gillespie et al.   NEW ENGLAND JOURNAL OF MEDICINE

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

(2014) Amina Jindani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review

(2014) Stefan H E Kaufmann et al.   Lancet Respiratory Medicine

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

(2013) Michele D Tameris et al.   LANCET

Global health 2035: a world converging within a generation

(2013) Dean T Jamison et al.   LANCET

Preventive vaccines for tuberculosis

(2013) Thomas G. Evans et al.   VACCINE

Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF

(2012) Karin Weyer et al.   EUROPEAN RESPIRATORY JOURNAL

Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis

(2012) Patrick P. J. Phillips et al.   JOURNAL OF INFECTIOUS DISEASES

Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade

(2012) Michael J. Brennan et al.   TUBERCULOSIS

The role of biomedical research in global tuberculosis control: gaps and challenges

(2012) Christine F Sizemore et al.   Emerging Microbes & Infections

Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies

(2011) Hanif Esmail et al.   DRUG DISCOVERY TODAY

Modeling social, environmental and biological determinants of tuberculosis

(2011) M. Murray et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Tuberculosis control and elimination 2010–50: cure, care, and social development

(2010) Knut Lönnroth et al.   LANCET

Tuberculosis: What We Don't Know Can, and Does, Hurt Us

(2010) D. G. Russell et al.   SCIENCE

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

(2009) U. Mack et al.   EUROPEAN RESPIRATORY JOURNAL

Drivers of tuberculosis epidemics: The role of risk factors and social determinants

(2009) Knut Lönnroth et al.   SOCIAL SCIENCE & MEDICINE

Eliminating human tuberculosis in the twenty-first century

(2007) C. Dye et al.   Journal of the Royal Society Interface